Survivin expression is largely restricted to cancerous tissues, where it has been associated with tumor aggressiveness, higher risk of recurrence, and shorter patient survival, as well as chemotherapy resistance in several cancer types, including PC [7,11,13,14,15,16]. This evidence concerns the gene BIRC5 and cancer.